Receptor-based 3D QSAR analysis of estrogen receptor ligands--merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods.

A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods. J Comput Aided Mol Des (2003) 1.02

Development of biologically active compounds by combining 3D QSAR and structure-based design methods. J Comput Aided Mol Des (2002) 0.87

CoMFA and docking study of novel estrogen receptor subtype selective ligands. J Comput Aided Mol Des (2003) 0.84

Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligands. J Comput Aided Mol Des (2008) 0.84

A validation study on the practical use of automated de novo design. J Comput Aided Mol Des (2002) 0.83

Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors. J Comput Aided Mol Des (2001) 0.81

SAR comparative studies on pyrimido[4,5-b][1,4] benzothiazine derivatives as 15-lipoxygenase inhibitors, using ab initio calculations. J Mol Model (2008) 0.78

Multiple receptor conformation docking and dock pose clustering as tool for CoMFA and CoMSIA analysis - a case study on HIV-1 protease inhibitors. J Mol Model (2011) 0.77

Structure-based prediction of free energy changes of binding of PTP1B inhibitors. J Comput Aided Mol Des (2003) 0.76

Pharmacophore search for anti-fertility and estrogenic potencies of estrogen analogs. J Mol Model (2008) 0.76

New Insight into the SAR of Pyrimido [4,5-b][1,4] Benzothiazines as 15-lipoxygenase Inhibitors. Iran J Basic Med Sci (2013) 0.75

Receptor guided 3D-QSAR: a useful approach for designing of IGF-1R inhibitors. J Biomed Biotechnol (2008) 0.75

The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol (1977) 90.57

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell (1998) 9.96

Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09

Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit (1996) 6.51

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc (1988) 6.41

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem (1985) 6.09

Structure-based strategies for drug design and discovery. Science (1992) 3.72

The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J Comput Aided Mol Des (1994) 3.12

Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs. J Comput Aided Mol Des (1998) 1.74

Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. J Med Chem (1999) 1.62

FLEXS: a method for fast flexible ligand superposition. J Med Chem (1998) 1.32

Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries. J Comput Aided Mol Des (1999) 1.17

Ligand-based identification of environmental estrogens. Chem Res Toxicol (1996) 1.17

The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands. J Mol Biol (1994) 1.15

QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes. Endocrinology (1997) 1.11

Ligand-protein docking and rational drug design. Curr Opin Struct Biol (1995) 1.02

Modelling of factor Xa-inhibitor complexes: a computational flexible docking approach. Proteins (1999) 1.01

Using three-dimensional quantitative structure-activity relationships to examine estrogen receptor binding affinities of polychlorinated hydroxybiphenyls. Environ Health Perspect (1995) 0.97

Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b. J Med Chem (1994) 0.93

CASP2 experiences with docking flexible ligands using FlexX. Proteins (1997) 0.92

Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules. J Med Chem (1993) 0.91

A structural and energetics analysis of the binding of a series of N-acetylneuraminic-acid-based inhibitors to influenza virus sialidase. J Comput Aided Mol Des (1996) 0.87

A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysis. J Med Chem (1997) 0.87

Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors. J Med Chem (1996) 0.85

Energetic and entropic factors determining binding affinity in protein-ligand complexes. J Recept Signal Transduct Res (1997) 0.85

Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach. J Med Chem (1998) 0.84

Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships. J Med Chem (1997) 0.84

Scoring functions: a view from the bench. J Comput Aided Mol Des (1999) 0.83

On the prediction of binding properties of drug molecules by comparative molecular field analysis. J Med Chem (1993) 0.82

Nonlinear dependence in comparative molecular field analysis. J Comput Aided Mol Des (1993) 0.82

Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors. J Comput Aided Mol Des (1996) 0.79

An approach to rapid estimation of relative binding affinities of enzyme inhibitors: application to peptidomimetic inhibitors of the human immunodeficiency virus type 1 protease. J Med Chem (1996) 0.77

Comparative molecular field analysis and energy interaction studies of thrombin-inhibitor complexes. J Comput Aided Mol Des (1999) 0.76

Evaluation of proposed modes of binding of (2S)-2-[4-[[(3S)-1-acetimidoyl-3-pyrrolidinyl]oxy]phenyl]-3-(7-am idino- 2- naphthyl)propanoic acid hydrochloride and some analogs to factor Xa using a comparative molecular field analysis. J Comput Aided Mol Des (1998) 0.75

Molecular modeling and 3D-QSAR studies on the interaction mechanism of tripeptidyl thrombin inhibitors with human alpha-thrombin. J Med Chem (1997) 0.75